Home › How Gilead Sciences Is Gouging Hepatitis C Patients, $1,000 a Pill
 

Keywords :   


How Gilead Sciences Is Gouging Hepatitis C Patients, $1,000 a Pill

2015-06-21 20:06:31| Biotech - Topix.net

A new wave of hepatitis C drugs is all the rage. But while these new pills boast cure rates of 90 percent in less time than their predecessors, their prices are causing rage.

Tags: sciences patients pill hepatitis

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Atlantic Tropical Weather Outlook
26.06Eastern North Pacific Tropical Weather Outlook
26.06XREAL bring Play Store apps to 3D space on XREAL AR glasses
26.06Qwilt reveals live streaming survey results
26.06Rockline Industries Wins WOW Innovation Award
26.06IMS Technologies Expands Calcinate Production Site
26.06Horizon expert 'gave evidence based on informal chats'
26.06Automotive Color by BASF Recognized with Renowned Red Dot Award
More »